Tissue Engineering with Decellularized Tissues

Biomaterials Science: An Introduction to Materials: Third Edition

Volumn , Issue , 2013, Pages 1316-1331

  Badylak, Stephen F ^a   Brown, Bryan N ^a   Gilbert, Thomas W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE;

DECELLULARIZED TISSUES;

TISSUE ENGINEERING;

EID: 84922748186     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-087780-8.00140-6     Document Type: Chapter

References (162)

1. Agrawal V., Brown B.N., Beattie A.J., Gilbert T.W., Badylak S.F. Evidence of innervation following extracellular matrix scaffold-mediated remodelling of muscular tissues. J. Tissue Eng. Regen. Med 2009.
2. Agrawal V., Johnson S.A., Reing J., Zhang L., Tottey S., Wang G., Hirschi K.K., Braunhut S., Gudas L.J., Badylak S.F. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc. Natl. Acad. Sci. U S A 2010, 107(8):3351-3355.
3. Agrawal V., Tottey S., Johnson S.A., Freund J.M., Siu B.F., Badylak S.F. Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng. Part A 2011, 17(19-20):2435-2443.
4. Agrawal V., Kelly J., Tottey S., Daly K.A., Johnson S.A., Siu B.F., Reing J., Badylak S.F. An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation. Tissue Eng. Part A 2011, 17(23-24):3033-3044.
5. Alini M., Li W., Markovic P., Aebi M., Spiro R.C., Roughley P.J. The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix. Spine 2003, 28(5):446-454. Discussion 53.
6. Allman A.J., McPherson T.B., Badylak S.F., Merrill L.C., Kallakury B., Sheehan C., et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 2001, 71(11):1631-1640.
7. Allman A.J., McPherson T.B., Merrill L.C., Badylak S.F., Metzger D.W. The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens. Tissue Eng. 2002, 8(1):53-62.
8. Almarza A.J., Yang G., Woo S.L., Nguyen T., Abramowitch S.D. Positive changes in bone marrow-derived cells in response to culture on an aligned bioscaffold. Tissue Eng. Part A. 2008, 14(9):1489-1495.
9. Altman G.H., Horan R.L., Martin I., Farhadi J., Stark P.R., Volloch V., et al. Cell differentiation by mechanical stress. FASEB J. 2002, 16(2):270-272.
10. Androjna C., Spragg R.K., Derwin K.A. Mechanical conditioning of cell-seeded small intestine submucosa: A potential tissue-engineering strategy for tendon repair. Tissue Eng. 2007, 13(2):233-243.
11. Armour A.D., Fish J.S., Woodhouse K.A., Semple J.L. A comparison of human and porcine acellularized dermis: Interactions with human fibroblasts In vitro. Plast. Reconstr. Surg. 2006, 117(3):845-856.
12. Bader A., Schilling T., Teebken O.E., Brandes G., Herden T., Steinhoff G., et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardiothorac. Surg. 1998, 14(3):279-284.
13. Badylak S.F., Lantz G.C., Coffey A., Geddes L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J. Surg. Res. 1989, 47(1):74-80.
14. Badylak S., Meurling S., Chen M., Spievack A., Simmons-Byrd A. Resorbable bioscaffold for esophageal repair in a dog model. J. Pediatr. Surg. 2000, 35(7):1097-1103.
15. Badylak S.F., Park K., Peppas N., McCabe G., Yoder M. Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp. Hematol. 2001, 29(11):1310-1318.
16. Badylak S., Kokini K., Tullius B., Simmons-Byrd A., Morff R. Morphologic study of small intestinal submucosa as a body wall repair device. J. Surg. Res. 2002, 103(2):190-202.
17. Badylak S.F., Vorp D.A., Spievack A.R., Simmons-Byrd A., Hanke J., Freytes D.O., et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J. Surg. Res. 2005, 128(1):87-97.
18. Badylak S.F., Kochupura P.V., Cohen I.S., Doronin S.V., Saltman A.E., Gilbert T.W., et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant. 2006, 15(Suppl. 1):S29-S40.
19. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. 2008, 14(11):1835-1842.
20. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 2009, 5(1):1-13.
21. Badylak S.F., Weiss D.J., Caplan A., Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012, 379(9819):943-952.
22. Baldwin H.S. Early embryonic vascular development. Cardiovasc. Res. 1996, 31 Spec. No: E34-45.
23. Barnard K., Gathercole L.J. Short and long range order in basement membrane type IV collagen revealed by enzymic and chemical extraction. Int. J. Biol. Macromol. 1991, 13(6):359-365.
24. Beattie A.J., Gilbert T.W., Guyot J.P., Yates A.J., Badylak S.F. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng. Part A. 2009, 15(5):1119-1125.
25. Bello Y.M., Falabella A.F., Eaglstein W.H. Tissue-engineered skin. Current status in wound healing. Am. J. Clin. Dermatol. 2001, 2(5):305-313.
26. Bernard MPC M.L., Myers J.C., Ramirez F., Eikenberry E.F., Prockop D.J. Nucleotide sequences of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution. Biochemistry 1983, 22:5213-5223.
27. Bernard MPM J.C., Chu M.L., Ramirez F., Eikenberry E.F., Prockop D.J. Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene. Biochemistry 1983, 22:1139-1145.
28. Bhrany A.D., Beckstead B.L., Lang T.C., Farwell D.G., Giachelli C.M., Ratner B.D. Development of an esophagus acellular matrix tissue scaffold. Tissue Eng. 2006, 12(2):319-330.
29. Billiar K., Murray J., Laude D., Abraham G., Bachrach N. Effects of carbodiimide crosslinking conditions on the physical properties of laminated intestinal submucosa. J. Biomed. Mater. Res. 2001, 56(1):101-108.
30. Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression?. J. Theor. Biol. 1982, 99(1):31-68.
31. Black A.F., Berthod F., L'Heureux N., Germain L., Auger F.A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb J. 1998, 12(13):1331-1340.
32. Bonewald L.F. Regulation and regulatory activities of transforming growth factor beta. Crit. Rev. Eukaryot. Gene. Expr. 1999, 9(1):33-44.
33. Borschel G.H., Dennis R.G., Kuzon W.M. Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr. Surg. 2004, 113(2):595-602. Discussion 603-594.
34. Boruch A.V., Nieponice A., Qureshi I.R., Gilbert T.W., Badylak S.F. Constructive remodeling of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a canine partial cystectomy model. J. Surg. Res 2009.
35. Boudreau N., Myers C., Bissell M.J. From laminin to lamin: Regulation of tissue-specific gene expression by the ECM. Trends Cell Biol. 1995, 5(1):1-4.
36. Brennan E.P., Reing J., Chew D., Myers-Irvin J.M., Young E.J., Badylak S.F. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng. 2006, 12(10):2949-2955.
37. Brennan E.P., Tang X.H., Stewart-Akers A.M., Gudas L.J., Badylak S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J. Tissue Eng. Regen. Med. 2008, 2(8):491-498.
38. Brown B.N., Londono R., Tottey S., Zhang L., Kukla K.A., Wolf M.T., Daly K.A., Reing J.E., Badylak S.F. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta. Biomater. 2012, 8(3):978-987.
39. Buinewicz B., Rosen B. Acellular cadaveric dermis (AlloDerm): A new alternative for abdominal hernia repair. Ann. Plast. Surg. 2004, 52(2):188-194.
40. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2008, 30(8):1482-1491.
41. Cartmell J.S., Dunn M.G. Development of cell-seeded patellar tendon allografts for anterior cruciate ligament reconstruction. Tissue Eng. 2004, 10(7-8):1065-1075.
42. Cartwright L.M., Shou Z., Yeger H., Farhat W.A. Porcine bladder acellular matrix porosity: Impact of hyaluronic acid and lyophilization. J. Biomed. Mater. Res. A. 2006, 77(1):180-184.
43. Causa F., Netti P.A., Ambrosio L. A multi-functional scaffold for tissue regeneration: The need to engineer a tissue analogue. Biomaterials 2007, 28(34):5093-5099.
44. Chen F., Yoo J.J., Atala A. Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. Urology 1999, 54(3):407-410.
45. Chun S.Y., Lim G.J., Kwon T.G., Kwak E.K., Kim B.W., Atala A., et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007, 28(29):4251-4256.
46. Clarke K.M., Lantz G.C., Salisbury S.K., Badylak S.F., Hiles M.C., Voytik S.L. Intestine submucosa and polypropylene mesh for abdominal wall repair in dogs. J. Surg. Res. 1996, 60(1):107-114.
47. Cobb M.A., Badylak S.F., Janas W., Boop F.A. Histology after dural grafting with small intestinal submucosa. Surg. Neurol. 1996, 46(4):389-393. Discussion 393-384.
48. Cobb M.A., Badylak S.F., Janas W., Simmons-Byrd A., Boop F.A. Porcine small intestinal submucosa as a dural substitute. Surg. Neurol. 1999, 51(1):99-104.
49. Collins B.H., Chari R.S., Magee J.C., Harland R.C., Lindman B.J., Logan J.S., et al. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation 1994, 58(11):1162-1171.
50. Constantinou CDJ S.A. Structure of cDNAs encoding the triple-helical domain of murine alpha 2 (VI) collagen chain and comparison to human and chick homologues. Use of polymerase chain reaction and partially degenerate oligonucleotide for generation of novel cDNA clones. Matrix 1991, 11:1-9.
51. Cooper D.K., Good A.H., Koren E., Oriol R., Malcolm A.J., Ippolito R.M., et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man. Transpl. Immunol. 1993, 1(3):198-205.
52. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32(12):3233-3243.
53. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008, 3(3):301-313.
54. Daly K., Stewart-Akers A., Hara H., Ezzelarab M., Long C., Cordero K., et al. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng. Part A. 2009, 15(12):3877-3888.
55. Dejana E., Colella S., Languino L.R., Balconi G., Corbascio G.C., Marchisio P.C. Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells In vitro. J. Cell Biol. 1987, 104(5):1403-1411.
56. Dejardin L.M., Arnoczky S.P., Ewers B.J., Haut R.C., Clarke R.B. Tissue-engineered rotator cuff tendon using porcine small intestine submucosa. Histologic and mechanical evaluation in dogs. Am. J. Sports Med. 2001, 29(2):175-184.
57. Derwin K.A., Baker A.R., Spragg R.K., Leigh D.R., Iannotti J.P. Commercial extracellular matrix scaffolds for rotator cuff tendon repair. Biomechanical, biochemical, and cellular properties. J. Bone Joint Surg. Am. 2006, 88(12):2665-2672.
58. Entwistle J., Zhang S., Yang B., Wong C., Li Q., Hall C.L., et al. Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene 1995, 163(2):233-238.
59. Erdag G., Morgan J.R. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts. Cell Transplant 2004, 13(6):701-712.
60. Exposito JYDA M., Solursh M., Ramirez F. Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2(I) collagen. J. Biol. Chem. 1992, 267:15559-15562.
61. Farhat W.A., Chen J., Haig J., Antoon R., Litman J., Sherman C., et al. Porcine bladder acellular matrix (ACM): Protein expression, mechanical properties. Biomed. Mater. 2008, 3(2):25015.
62. Freise C., Erben U., Muche M., Farndale R., Zeitz M., Somasundaram R., et al. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol. 2009, 28(8):480-489.
63. Freytes D.O., Badylak S.F., Webster T.J., Geddes L.A., Rundell A.E. Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 2004, 25(12):2353-2361.
64. Freytes D.O., Martin J., Velankar S.S., Lee A.S., Badylak S.F. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 2008, 29(11):1630-1637.
65. Galili U., Macher B.A., Buehler J., Shohet S.B. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues. J. Exp. Med. 1985, 162(2):573-582.
66. Gilbert T.W., Stolz D.B., Biancaniello F., Simmons-Byrd A., Badylak S.F. Production and characterization of ECM powder: Implications for tissue engineering applications. Biomaterials 2005, 26(12):1431-1435.
67. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27(19):3675-3683.
68. Gilbert T.W., Stewart-Akers A.M., Simmons-Byrd A., Badylak S.F. Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair. J. Bone Joint Surg. Am. 2007, 89(3):621-630.
69. Gilbert T.W., Stewart-Akers A.M., Badylak S.F. A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 2007, 28(2):147-150.
70. Gilbert T.W., Stewart-Akers A.M., Sydeski J., Nguyen T.D., Badylak S.F., Woo SL- Y. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng. 2007, 13(6):1313-1323.
71. Gilbert T.W., Stewart-Akers A.M., Simmons-Byrd A., Badylak S.F. Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair. J. Bone Joint Surg. Am. 2007, 89(3):621-630.
72. Gilbert T.W., Gilbert S., Madden M., Reynolds S.D., Badylak S.F. Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann. Thorac. Surg. 2008, 86(3):967-974. discussion 967-974.
73. Gilbert T.W., Nieponice A., Spievack A.R., Holcomb J., Gilbert S., Badylak S.F. Repair of the thoracic wall with an extracellular matrix scaffold in a canine model. J. Surg. Res. 2008, 147(1):61-67.
74. Gilbert T.W., Agrawal V., Gilbert M.R., Povirk K.M., Badylak S.F., Rosen C.A. Liver-derived extracellular matrix as a biologic scaffold for acute vocal fold repair in a canine model. Laryngoscope 2009, 119(9):1856-1863.
75. Gilbert T.W., Freund J.M., Badylak S.F. Quantification of DNA in biologic scaffold materials. J. Surg. Res. 2009, 152(1):135-139.
76. Glowacki J., Mizuno S. Collagen scaffolds for tissue engineering. Biopolymers 2008, 89(5):338-344.
77. Gock H., Murray-Segal L., Salvaris E., Cowan P., D'Apice A.J. Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting Gal-mediated skin graft rejection. Transplantation 2004, 77(5):751-753.
78. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5(12):953-964.
79. Hammond J.S., Gilbert T.W., Howard D., Zaitoun A., Michalopoulos G., Shakesheff K.M., Beckingham I.J., Badylak S.F. Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J. Hepatol. 2011, 54(2):279-287.
80. Harper C. Permacol: Clinical experience with a new biomaterial. Hosp. Med. 2001, 62(2):90-95.
81. Haviv F., Bradley M.F., Kalvin D.M., Schneider A.J., Davidson D.J., Majest S.M., et al. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities. J. Med. Chem. 2005, 48(8):2838-2846.
82. Hodde J.P., Badylak S.F., Brightman A.O., Voytik-Harbin S.L. Glycosaminoglycan content of small intestinal submucosa: A bioscaffold for tissue replacement. Tissue Eng. 1996, 2(3):209-217.
83. Hodde J.P., Badylak S.F., Shelbourne K.D. The effect of range of motion on remodeling of small intestinal submucosa (SIS) when used as an Achilles tendon repair material in the rabbit. Tissue Eng. 1997, 3(1):27-37.
84. Hodde J.P., Record R.D., Tullius R.S., Badylak S.F. Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization. Tissue Eng. 2002, 8(2):225-234.
85. Holtom P.D., Shinar Z., Benna J., Patzakis M.J. Porcine small intestine submucosa does not show antimicrobial properties. Clin. Orthop. Relat. Res. 2004, (427):18-21.
86. Huber J.E., Spievack A., Simmons-Byrd A., Ringel R.L., Badylak S. Extracellular matrix as a scaffold for laryngeal reconstruction. Ann. Otol. Rhinol. Laryngol. 2003, 112(5):428-433.
87. Hudson T.W., Liu S.Y., Schmidt C.E. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng. 2004, 10(9-10):1346-1358.
88. Ingber D. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J. Cell. Biochem. 1991, 47(3):236-241.
89. Kagami S., Kondo S., Loster K., Reutter W., Urushihara M., Kitamura A., et al. Collagen type I modulates the platelet-derived growth factor (PDGF) regulation of the growth and expression of beta1 integrins by rat mesangial cells. Biochem. Biophys. Res. Commun. 1998, 252(3):728-732.
90. Kim B.S., Yoo J.J., Atala A. Peripheral nerve regeneration using acellular nerve grafts. J. Biomed. Mater. Res. A. 2004, 68(2):201-209.
91. Koh H.S., Yong T., Chan C.K., Ramakrishna S. Enhancement of neurite outgrowth using nano-structured scaffolds coupled with laminin. Biomaterials 2008, 29(26):3574-3582.
92. Lantz G.C., Badylak S.F., Coffey A.C., Geddes L.A., Blevins W.E. Small intestinal submucosa as a small-diameter arterial graft in the dog. J. Invest. Surg. 1990, 3(3):217-227.
93. Lantz G.C., Badylak S.F., Hiles M.C., Coffey A.C., Geddes L.A., Kokini K., et al. Small intestinal submucosa as a vascular graft: A review. J. Invest Surg. 1993, 6(3):297-310.
94. Laurie G.W., Horikoshi S., Killen P.D., Segui-Real B., Yamada Y. In situ hybridization reveals temporal and spatial changes in cellular expression of mRNA for a laminin receptor, laminin, and basement membrane (type IV) collagen in the developing kidney. J. Cell Biol. 1989, 109(3):1351-1362.
95. Li F., Li W., Johnson S., Ingram D., Yoder M., Badylak S. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 2004, 11(3-4):199-206.
96. Li S., Harrison D., Carbonetto S., Fassler R., Smyth N., Edgar D., et al. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J. Cell Biol. 2002, 157(7):1279-1290.
97. Lin P., Chan W.C., Badylak S.F., Bhatia S.N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 2004, 10(7-8):1046-1053.
98. Lin P., Chan W.C., Badylak S.F., Bhatia S.N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 2004, 10(7-8):1046-1053.
99. Lovekamp J.J., Simionescu D.T., Mercuri J.J., Zubiate B., Sacks M.S., Vyavahare N.R. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 2006, 27(8):1507-1518.
100. Macarak E.J., Howard P.S. Adhesion of endothelial cells to extracellular matrix proteins. J. Cell Physiol. 1983, 116(1):76-86.
101. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372(9655):2023-2030.
102. Manni M.L., Czajka C.A., Oury T.D., Gilbert T.W. Extracellular matrix powder protects against bleomycin-induced pulmonary fibrosis. Tissue Eng. Part A. 2011, 17(21-22):2795-2804.
103. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25(12):677-686.
104. Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity 2005, 23(4):344-346.
105. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
106. Martins-Green M., Bissel M.F. Cell-extracellular matrix interactions in development. Semin. Dev. Biol. 1995, 6:149-159.
107. Matziolis G., Tuischer J., Kasper G., Thompson M., Bartmeyer B., Krocker D., et al. Simulation of cell differentiation in fracture healing: Mechanically loaded composite scaffolds in a novel bioreactor system. Tissue Eng. 2006, 12(1):201-208.
108. McPherson T., Badylak S.F. Characterization of fibronectin derived from porcine small intestinal submucosa. Tissue Eng. 1998, 4:75-83.
109. McPherson T.B., Liang H., Record R.D., Badylak S.F. Galalpha(1,3)Gal epitope in porcine small intestinal submucosa. Tissue Eng. 2000, 6(3):233-239.
110. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164(12):6166-6173.
111. Miyamoto S., Katz B.Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling and morphogenesis. Ann. N. Y. Acad. Sci. 1998, 857:119-129.
112. Moore D.C., Pedrozo H.A., Crisco J.J., Ehrlich M.G. Preformed grafts of porcine small intestine submucosa (SIS) for bridging segmental bone defects. J. Biomed. Mater. Res. A. 2004, 69(2):259-266.
113. Mosser D.M. The many faces of macrophage activation. J. Leukocyte Biol. 2003, 73(2):209-212.
114. Mostow E.N., Haraway G.D., Dalsing M., Hodde J.P., King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial. J. Vasc. Surg. 2005, 41(5):837-843.
115. Nguyen T.D., Liang R., Woo S.L.-Y., Burton S.D., Wu C., Almarza A., et al. Effects of cell seeding and cyclic stretch on the fiber remodeling in an extracellular matrix-derived bioscaffold. Tissue Eng. Part A. 2009, 15(4):957-963.
116. Nichols J.E., Niles J.A., Cortiella J. Design and development of tissue engineered lung: Progress and challenges. Organogenesis 2009, 5(2):57-61.
117. Nieponice A., Gilbert T.W., Badylak S.F. Reinforcement of esophageal anastomoses with an extracellular matrix scaffold in a canine model. Ann. Thorac. Surg. 2006, 82(6):2050-2058.
118. Nieponice A., Maul T.M., Cumer J.M., Soletti L., Vorp D.A. Mechanical stimulation induces morphological and phenotypic changes in bone marrow-derived progenitor cells within a three-dimensional fibrin matrix. J. Biomed. Mater. Res. A. 2007, 81(3):523-530.
119. Nieponice A., McGrath K., Qureshi I., Beckman E.J., Luketich J.D., Gilbert T.W., et al. An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc. 2009, 69(2):289-296.
120. Oriol R., Ye Y., Koren E., Cooper D.K. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993, 56(6):1433-1442.
121. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat. Med. 2008, 14(2):213-221.
122. Parekh A., Mantle B., Banks J., Swarts J.D., Badylak S.F., Dohar J.E., et al. Repair of the tympanic membrane with urinary bladder matrix. Laryngoscope 2009, 119(6):1206-1213.
123. Peel S.A.F., Chen H., Renlund R., Badylak S.F., Kandel R.A. Formation of a SIS-cartilage composite graft In vitro and its use in the repair of articular cartilage defects. Tissue Eng. 1998, 4(2):143-155.
124. Petersen T.H., Calle E.A., Colehour M.B., Niklason L.E. Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 2012, 195(3):222-231.
125. Piechota H.J., Dahms S.E., Probst M., Gleason C.A., Nunes L.S., Dahiya R., et al. Functional rat bladder regeneration through xenotransplantation of the bladder acellular matrix graft. Br. J. Urol. 1998, 81(4):548-559.
126. Piez K.A. Molecular and Aggregate Structures of The Collagens 1984, Elsevier, New York.
127. Ponce M.L., Nomizu M., Delgado M.C., Kuratomi Y., Hoffman M.P., Powell S., et al. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ. Res. 1999, 84(6):688-694.
128. Prevel C.D., Eppley B.L., Summerlin D.J., Jackson J.R., McCarty M., Badylak S.F. Small intestinal submucosa: Utilization for repair of rodent abdominal wall defects. Ann. Plast. Surg. 1995, 35(4):374-380.
129. Prevel C.D., Eppley B.L., Summerlin D.J., Sidner R., Jackson J.R., McCarty M., et al. Small intestinal submucosa: utilization as a wound dressing in full-thickness rodent wounds. Ann. Plast. Surg. 1995, 35(4):381-388.
130. Price A.P., England K.A., Matson A.M., Blazar B.R., Panoskaltsis-Mortari A. Development of a decellularized lung bioreactor system for bioengineering the lung: The matrix reloaded. Tissue Eng. Part A. 2010, 16(8):2581-2591.
131. Raeder R.H., Badylak S.F., Sheehan C., Kallakury B., Metzger D.W. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl. Immunol. 2002, 10(1):15-24.
132. Record R.D., Hillegonds D., Simmons C., Tullius R., Rickey F.A., Elmore D., Badylak S.F. In vivo degradation of 14C-labeled small intestinal submucosa (SIS) when used for urinary bladder repair. Biomaterials 2001, 22(19):2653-2659.
133. Reing J.E., Zhang L., Myers-Irvin J., Cordero K.E., Freytes D.O., Heber-Katz E., et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng. Part A. 2009, 15(3):605-614.
134. Remlinger N.T., Czajka C.A., Juhas M.E., Vorp D.A., Stolz D.B., Badylak S.F., Gilbert S., Gilbert T.W. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction. Biomaterials 2010, 31(13):3520-3526.
135. Roberts R., Gallagher J., Spooncer E., Allen T.D., Bloomfield F., Dexter T.M. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis. Nature 1988, 332(6162):376-378.
136. Ross J.R., Kirk A.D., Ibrahim S.E., Howell D.N., Baldwin W.M., Sanfilippo F.P. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts - predominance of IgM and IgG2. Transplantation 1993, 55(5):1144-1150.
137. Sandusky G.E., Badylak S.F., Morff R.J., Johnson W.D., Lantz G. Histologic findings after In vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am. J. Pathol. 1992, 140(2):317-324.
138. Sarikaya A., Record R., Wu C.C., Tullius B., Badylak S., Ladisch M. Antimicrobial activity associated with extracellular matrices. Tissue Eng. 2002, 8(1):63-71.
139. Schwarzbauer J.E. Fibronectin: From gene to protein. Curr. Opin. Cell Biol. 1991, 3(5):786-791.
140. Schwarzbauer J. Basement membranes: Putting up the barriers. Curr. Biol. 1999, 9(7):R242-R244.
141. Sondell M., Lundborg G., Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res. 1998, 795(1-2):44-54.
142. Song J.J., Kim S.S., Liu Z., Madsen J.C., Mathisen D.J., Vacanti J.P., Ott H.C. Enhanced In vivo function of bioartificial lungs in rats. Ann. Thorac. Surg. 2011, 92(3):998-1005.
143. Soto-Gutierrez A., Zhang L., Medberry C., Fukumitsu K., Faulk D., Jiang H., Reing J., Gramignoli R., Komori J., Ross M., Nagaya M., Legasse E., Stolz D., Strom S.C., Fox I.J., Badylak S.F. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng. Part C Methods 2011, 17(6):677-686.
144. Suckow M.A., Voytik-Harbin S.L., Terril L.A., Badylak S.F. Enhanced bone regeneration using porcine small intestinal submucosa. J. Invest Surg. 1999, 12(5):277-287.
145. Timpl R. Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 1996, 8(5):618-624.
146. Timpl R., Brown J.C. Supramolecular assembly of basement membranes. Bioessays 1996, 18(2):123-132.
147. Tischer T., Vogt S., Aryee S., Steinhauser E., Adamczyk C., Milz S., et al. Tissue engineering of the anterior cruciate ligament: A new method using acellularized tendon allografts and autologous fibroblasts. Arch. Orthop. Trauma Surg. 2007, 127(9):735-741. Tissue Eng Regen Med 2008 Dec;2(8):491-498.
148. Uygun B.E., Soto-Gutierrez A., Yagi H., Izamis M.L., Guzzardi M.A., Shulman C., Milwid J., Kobayashi N., Tilles A., Berthiaume F., Hertl M., Nahmias Y., Yarmush M.L., Uygun K. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 2010, 16(7):814-820.
149. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J. Bone Joint. Surg. Am. 2006, 88(12):2673-2686.
150. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng. Part A. 2009, 15(7):1687-1694.
151. Valentin J.E., Turner N.J., Gilbert T.W., Badylak S.F. Functional skeletal muscle formation with a biologic scaffold. Biomaterials 2010, 31(29):7475-7484.
152. van der Rest M., Garrone R. Collagen family of proteins. Faseb J. 1991, 5(13):2814-2823.
153. Verreck F.A., de Boer T., Langenberg D.M., van der Zanden L., Ottenhoff T.H. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukocyte Biol. 2006, 79(2):285-293.
154. Wainwright J.M., Czajka C.A., Patel U.B., Freytes D.O., Tobita K., Gilbert T.W., et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng. Part C: Methods 2010, 16(3):525-532.
155. Wallis M.C., Yeger H., Cartwright L., Shou Z., Radisic M., Haig J., et al. Feasibility study of a novel urinary bladder bioreactor. Tissue Eng. Part A. 2008, 14(3):339-348.
156. Welch J.A., Montgomery R.D., Lenz S.D., Plouhar P., Shelton W.R. Evaluation of small-intestinal submucosa implants for repair of meniscal defects in dogs. Am. J. Vet. Res. 2002, 63(3):427-431.
157. Werb Z., Vu T.H., Rinkenberger J.L., Coussens L.M. Matrix-degrading proteases and angiogenesis during development and tumor formation. Apmis 1999, 107(1):11-18.
158. Woods T., Gratzer P.F. Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 2005, 26(35):7339-7349.
159. Yoo J.J., Meng J., Oberpenning F., Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 1998, 51(2):221-225.
160. Yurchenco P., Birk D.E., Mecham R.P. Extracellular Matrix Assembly and Structure 1994, San Diego: Academic Press.
161. Zantop T., Gilbert T.W., Yoder M.C., Badylak S.F. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. J. Orthop. Res. 2006, 24(6):1299-1309.
162. Zheng M.H., Chen J., Kirilak Y., Willers C., Xu J., Wood D. Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: Possible implications in human implantation. J. Biomed. Mater. Res. B. Appl. Biomater. 2005, 73(1):61-67.